This is the authors' abstract. We don't add key points for this paper.
Linear, 2-arm branched, and 4-arm starlike peptides are designed and their antimicrobial and hemolytic activities are characterized. Branching molecular designs are demonstrated to enhance antimicrobial activity and reduce undesired hemolysis, leading to better selectivity towards microbes over mammalian cells. This unique strategy can also be applied to optimize the molecular structures of other types of macromolecular antimicrobials such as polymers.
No takes yet. Share an insight, caveat, or question.
Wiradharma et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: